{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T14:17:28Z","timestamp":1769350648301,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["107361"],"award-info":[{"award-number":["107361"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["109188"],"award-info":[{"award-number":["109188"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.taap.2012.03.012","type":"journal-article","created":{"date-parts":[[2012,3,27]],"date-time":"2012-03-27T00:56:00Z","timestamp":1332809760000},"page":"66-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["The lipid lowering drug lovastatin protects against doxorubicin-induced hepatotoxicity"],"prefix":"10.1016","volume":"261","author":[{"given":"Christian","family":"Henninger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Huelsenbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Huelsenbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Gr\u00f6sch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arno","family":"Schad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl J.","family":"Lackner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Kaina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2012.03.012_bb0005","first-page":"2223","article-title":"Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells","volume":"5","author":"Agarwal","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2012.03.012_bb0010","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bcp.2009.09.021","article-title":"Statins inhibit aminoglycoside accumulation and cytotoxicity to renal proximal tubule cells","volume":"79","author":"Antoine","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2012.03.012_bb0015","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1200\/JCO.2006.06.3560","article-title":"Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials","volume":"24","author":"Bonovas","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2012.03.012_bb0020","doi-asserted-by":"crossref","first-page":"22173","DOI":"10.1074\/jbc.272.35.22173","article-title":"Fas- or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-terminal kinase\/p38 kinases and GADD153","volume":"272","author":"Brenner","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2012.03.012_bb0025","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/carcin\/bgi036","article-title":"Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells","volume":"26","author":"Cafforio","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.taap.2012.03.012_bb0030","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.295.1.74","article-title":"Statins and cancer risk: a meta-analysis","volume":"295","author":"Dale","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.taap.2012.03.012_bb0035","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/sj.bjp.0706953","article-title":"Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide","volume":"149","author":"Damrot","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2012.03.012_bb0040","first-page":"158","article-title":"Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications","volume":"7","author":"Dimitroulakos","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2012.03.012_bb0045","doi-asserted-by":"crossref","first-page":"466","DOI":"10.7150\/ijbs.5.466","article-title":"Histopathological effects of cisplatin, doxorubicin and 5-flurouracil (5-FU) on the liver of male albino rats","volume":"5","author":"El-Sayyad","year":"2009","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.taap.2012.03.012_bb0050","first-page":"2044","article-title":"Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice","volume":"6","author":"Feleszko","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2012.03.012_bb0055","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2174\/187152508785909474","article-title":"Anthracycline-induced cardiotoxicity","volume":"6","author":"Ferreira","year":"2008","journal-title":"Cardiovasc. Hematol. Agents Med. Chem."},{"key":"10.1016\/j.taap.2012.03.012_bb0060","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2174\/156800909789057033","article-title":"Targeting the mevalonate pathway for improved anticancer therapy","volume":"9","author":"Fritz","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.taap.2012.03.012_bb0065","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0006-2952(98)00307-4","article-title":"A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin","volume":"57","author":"Gewirtz","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2012.03.012_bb0070","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1200\/JCO.2007.14.9401","article-title":"Anthracycline cardiotoxicity: from bench to bedside","volume":"26","author":"Gianni","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2012.03.012_bb0075","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/0960327107076885","article-title":"Protective effect of N-acetylcysteine, caffeic acid and vitamin E on doxorubicin hepatotoxicity","volume":"26","author":"Gokcimen","year":"2007","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.taap.2012.03.012_bb0080","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.molcel.2007.11.015","article-title":"The DNA damage response: ten years after","volume":"28","author":"Harper","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.taap.2012.03.012_bb0085","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1158\/1078-0432.CCR-07-0625","article-title":"Pravastatin inhibits the Rho\/CCN2\/extracellular matrix cascade in human fibrosis explants and improves radiation-induced intestinal fibrosis in rats","volume":"13","author":"Haydont","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2012.03.012_bb0090","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.ijrobp.2007.03.044","article-title":"Successful mitigation of delayed intestinal radiation injury using pravastatin is not associated with acute injury improvement or tumor protection","volume":"68","author":"Haydont","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.taap.2012.03.012_bb0210","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1038\/cddis.2011.65","article-title":"Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity","volume":"2","author":"Huelsenbeck","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.taap.2012.03.012_bb0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tox.2004.12.003","article-title":"Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats. The effects of vitamin E and catechin","volume":"209","author":"Kalender","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2012.03.012_bb0105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0022-3565(24)35291-7","article-title":"Metallothionein acts as a cytoprotectant against doxorubicin toxicity","volume":"292","author":"Kimura","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2012.03.012_bb0110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1634\/theoncologist.6-2-162","article-title":"Hepatotoxicity of chemotherapy","volume":"6","author":"King","year":"2001","journal-title":"Oncologist"},{"key":"10.1016\/j.taap.2012.03.012_bb0115","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1093\/nar\/gkn550","article-title":"Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin","volume":"36","author":"Kinner","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.taap.2012.03.012_bb0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pharmthera.2009.01.002","article-title":"Statins and cardioprotection\u2014more than just lipid lowering?","volume":"122","author":"Ludman","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.taap.2012.03.012_bb0125","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1158\/0008-5472.CAN-07-1649","article-title":"Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane","volume":"67","author":"Lyu","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2012.03.012_bb0130","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1021\/tx800002r","article-title":"Cardiotoxicity of antitumor drugs","volume":"21","author":"Menna","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2012.03.012_bb0135","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.bcp.2009.06.016","article-title":"Statins inhibit Akt\/PKB signaling via P2X7 receptor in pancreatic cancer cells","volume":"78","author":"Mistafa","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2012.03.012_bb0140","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/carcin\/15.9.2045","article-title":"Prevention of 1,2-dimethylhydrazine-induced colon tumorigenesis by HMG-CoA reductase inhibitors, pravastatin and simvastatin, in ICR mice","volume":"15","author":"Narisawa","year":"1994","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.taap.2012.03.012_bb0145","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1158\/1078-0432.CCR-05-1903","article-title":"Lovastatin protects human endothelial cells from killing by ionizing radiation without impairing induction and repair of DNA double-strand breaks","volume":"12","author":"Nuebel","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2012.03.012_bb0150","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.radonc.2009.06.020","article-title":"Lovastatin attenuates ionizing radiation-induced normal tissue damage in vivo","volume":"92","author":"Ostrau","year":"2009","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.taap.2012.03.012_bb0155","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1038\/sj.onc.1202322","article-title":"Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53","volume":"17","author":"Rao","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.taap.2012.03.012_bb0160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1253\/circj.CJ-08-0817","article-title":"Importance of Rac1 signaling pathway inhibition in the pleiotropic effects of HMG-CoA reductase inhibitors","volume":"73","author":"Rashid","year":"2009","journal-title":"Circ. J."},{"key":"10.1016\/j.taap.2012.03.012_bb0165","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1158\/0008-5472.CAN-08-3076","article-title":"Pretreatment with statin attenuates the cardiotoxicity of Doxorubicin in mice","volume":"69","author":"Riad","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2012.03.012_bb0170","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1073\/pnas.0830918100","article-title":"Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses","volume":"100","author":"Rothkamm","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2012.03.012_bb0175","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/carcin\/bgp061","article-title":"Ceramide synthases and ceramide levels are increased in breast cancer tissue","volume":"30","author":"Schiffmann","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.taap.2012.03.012_bb0180","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1734-1140(09)70018-0","article-title":"Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron","volume":"61","author":"Simunek","year":"2009","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.taap.2012.03.012_bb0185","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3109\/10715762.2010.507670","article-title":"Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases","volume":"44","author":"Singh","year":"2010","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.taap.2012.03.012_bb0190","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1126\/science.6093249","article-title":"Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II","volume":"226","author":"Tewey","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.taap.2012.03.012_bb0195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/380075a0","article-title":"Requirement for ceramide-initiated SAPK\/JNK signalling in stress-induced apoptosis","volume":"380","author":"Verheij","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.taap.2012.03.012_bb0200","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.yjmcc.2009.07.024","article-title":"Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity","volume":"47","author":"Yoshida","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.taap.2012.03.012_bb0205","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1253\/circj.CJ-10-0110","article-title":"Pleiotropic effects of statins \u2014 basic research and clinical perspectives","volume":"74","author":"Zhou","year":"2010","journal-title":"Circ. J."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X12001159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X12001159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:40:58Z","timestamp":1758573658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X12001159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0041008X12001159"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2012.03.012","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The lipid lowering drug lovastatin protects against doxorubicin-induced hepatotoxicity","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2012.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}